Generic placeholder image

Current Molecular Medicine

Author(s): Nurshamimi Nor Rashid*

DOI: 10.2174/1566524021666211117145216

DownloadDownload PDF Flyer Cite As
The Pandemic of Coronavirus Disease 2019 (COVID-19)

Page: [761 - 765] Pages: 5

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Currently, the world is facing the emergence of a virus that causes pneumonia in humans, which has a higher probability of causing complications, including respiratory distress syndrome and death. The new coronavirus 2019 (2019-nCoV), which is currently known as SARS-CoV-2, is the cause of the Coronavirus disease 2019 (COVID-19). This virus was first detected in Wuhan, Hubei Province of China, and appears to have been a zoonotic infection that has now adapted to humans. On March 11, 2020, COVID-19 was announced as a pandemic by the World Health Organisation (WHO), causing widespread panic worldwide. SARS-CoV-2 is genetically similar to the 2003 Severe Acute Respiratory Syndrome-related (SARS) and shares many similarities with the disease features of influenza virus infection. Scientists around the world are racing towards the development of vaccines and antivirals for COVID-19. This review will provide an update of COVID-19, a brief review of the symptoms and route of transmission of the SARS-CoV-2 virus, the reason why it is highly infectious, as well as the currently available treatments and comorbidities.

Keywords: Coronavirus disease 2019, COVID-19, SARS-CoV-2, influenza, pandemic, infection.

[1]
Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization (WHO) 2020. Archived from the original on February 28 2020.
[2]
Hui DS. I Azhar E, Madani TA. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-6.
[http://dx.doi.org/10.1016/j.ijid.2020.01.009] [PMID: 31953166]
[3]
Coronavirus: What is a pandemic and why use the term now?. BBC News 2020.
[4]
Coronavirus Disease 2019 (COVID-19) Symptoms.Centers for Disease Control and Prevention February 10 2020. Archived from the original on January 30 2020.
[5]
Anosmia Hyposmia. and Dysgeusia Symptoms of Coronavirus Disease American Academy of Otolaryngology-Head and neck surgery March 22 2020 Archived from the original on March 24 2020 Retrieved March 25 2020
[6]
What is a pandemic, and does it change the approach to coronavirus? The guardian.com 2020.
[7]
Q&A on coronaviruses. World Health Organization (WHO) Archived from the original on January 20 2020. Retrieved January 27 2020.
[8]
Coronavirus (COVID-19) Mortality Rate. 2020 Available from: www.worldometers.infoMarch 5 2020.
[9]
How does the coronavirus compare with the flu? The New York Times, August 25, 2020.
[10]
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433.
[11]
Li Q, Guan X, Wu P. Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382(13): 1199-207.
[http://dx.doi.org/10.1056/NEJMoa2001316] [PMID: 31995857]
[12]
Liu J, Liao X, Qian S. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 2020; 26(6): 1320-3.
[http://dx.doi.org/10.3201/eid2606.200239] [PMID: 32125269]
[13]
Chan JF, Yuan S, Kok KH. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395(10223): 514-23.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]
[14]
World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020. Available from: https://www.who.int/docs/default- source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
[15]
Ong SWX, Tan YK, Chia PY. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020; 323(16): 1610-2.
[http://dx.doi.org/10.1001/jama.2020.3227] [PMID: 32129805]
[16]
Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis 2020; 94: 44-8.
[http://dx.doi.org/10.1016/j.ijid.2020.03.004] [PMID: 32171952]
[17]
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020; 92(4): 418-23.
[http://dx.doi.org/10.1002/jmv.25681] [PMID: 31967327]
[18]
Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Virus Res 2018; 100: 163-88.
[http://dx.doi.org/10.1016/bs.aivir.2018.01.001] [PMID: 29551135]
[19]
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 2015; 1282: 1-23.
[http://dx.doi.org/10.1007/978-1-4939-2438-7_1] [PMID: 25720466]
[20]
Lu R, Zhao X, Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565-74.
[http://dx.doi.org/10.1016/S0140-6736(20)30251-8] [PMID: 32007145]
[21]
Zhou P, Yang XL, Wang XG. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[22]
Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020; 176: 104742.
[http://dx.doi.org/10.1016/j.antiviral.2020.104742] [PMID: 32057769]
[23]
Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol 2010; 84(24): 12658-64.
[http://dx.doi.org/10.1128/JVI.01542-10] [PMID: 20926566]
[24]
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol 2019; 93(6): e01815-e018118.
[http://dx.doi.org/10.1128/JVI.01815-18] [PMID: 30626688]
[25]
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17(3): 181-92.
[http://dx.doi.org/10.1038/s41579-018-0118-9] [PMID: 30531947]
[26]
Cheng PK, Wong DA, Tong LK. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 2004; 363(9422): 1699-700.
[http://dx.doi.org/10.1016/S0140-6736(04)16255-7] [PMID: 15158632]
[27]
Frieman MB, Chen J, Morrison TE. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog 2010; 6(4): e1000849.
[http://dx.doi.org/10.1371/journal.ppat.1000849] [PMID: 20386712]
[28]
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011; 81: 85-164.
[http://dx.doi.org/10.1016/B978-0-12-385885-6.00009-2] [PMID: 22094080]
[29]
Jin Y-H, Cai L, Cheng Z-S. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020; 7(1): 4.
[http://dx.doi.org/10.1186/s40779-020-0233-6] [PMID: 32029004]
[30]
Wang M, Cao R, Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; 30(3): 269-71.
[http://dx.doi.org/10.1038/s41422-020-0282-0] [PMID: 32020029]
[31]
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367: 1260-3.
[32]
Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020; 22(2): 69-71.
[http://dx.doi.org/10.1016/j.micinf.2020.01.004] [PMID: 32032682]
[33]
Coronavirus cases. Worldometer Info.
[34]
Heaton PM. The Covid-19 Vaccine-Development Multiverse. N Engl J Med 2020; 383(20): 1986-8.
[http://dx.doi.org/10.1056/NEJMe2025111] [PMID: 32663910]
[35]
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020; 14(3): 247-50.
[http://dx.doi.org/10.1016/j.dsx.2020.03.013] [PMID: 32247212]
[36]
Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalised patients with 2019 Novel Coronavirus–Infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061-9.
[http://dx.doi.org/10.1001/jama.2020.1585] [PMID: 32031570]